Nakamura Y, Matsuo J, Miyamoto N, Ojima A, Ando K, Kanda Y, Sawada K, Sugiyama A, and Sekino Y
J Pharmacol Sci 124(4):494-501
Publication Date: April 2, 2014
Product Type: iCell Cardiomyocytes
The experimental robustness of iCell Cardiomyocytes was tested across three independent laboratories. hERG channel (IKr) block was assessed via MEA-measured field potential duration prolongation in each laboratory and found to be equivalent.
These data demonstrate that iCell Cardiomyocytes utilized in standardized protocols provide inter-facility robustness and repeatability.